Saudi Arabia Announces Participation in Horticulture Expo 2023 in Doha

A night view of Doha, Qatar. (AFP)
A night view of Doha, Qatar. (AFP)
TT

Saudi Arabia Announces Participation in Horticulture Expo 2023 in Doha

A night view of Doha, Qatar. (AFP)
A night view of Doha, Qatar. (AFP)

Saudi Arabia announced on Sunday its participation in Expo 2023 Doha for Horticulture to show its efforts in facing environmental challenges.

Held under the theme “Green Desert, Better Environment”, Expo 2023 Doha for Horticulture will focus on inspiring and informing people about creative methods to mitigate and minimize desertification.

Head Director of Saudi Arabia’s participation Saleh Bindakhil explained that the Saudi participation in the Expo is part of its efforts and contributions to achieving environmental sustainability through the ambitious Vision 2030 initiatives.

He added that Saudi Arabia will work to lead the next green era by launching many programs, such as the Saudi Green and Middle East Green initiatives. The initiatives have a role in achieving a green future for all, food security, and improving the quality of life.

The Saudi Pavilion at Expo Doha 2023 will feature many sections that reflect the diversity and richness of the Kingdom. The projects of the 2030 Vision will be highlighted, such as the sustainability projects, programs that focus on boosting food security, and transformation of agriculture through modern technology, hydroponics and horticultural.



King Fahd Medical City, Boston Oncology Sign MoU for Localization of Gene and Target Cell Therapy

The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA
The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA
TT

King Fahd Medical City, Boston Oncology Sign MoU for Localization of Gene and Target Cell Therapy

The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA
The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA

Saudi Arabia’s King Fahd Medical City and Boston Oncology have signed a Memorandum of Understanding (MoU) for a project to localize gene and target cell therapy.

The project will be held at King Fahd Medical City, one of the components of the Riyadh Second Health Cluster, the Saudi Press Agency (SPA) reported Monday.
The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj.

The Saudi Deputy Minister for Planning and Development Eng. Abdulaziz Al-Rumaih attended the signing ceremony at the Saudi Ministry of Health.

AlGhofaili affirmed that the MoU aligns with the Medical City's plans towards the objectives of the Saudi Transformation Program in Healthcare Sector, which contributes to the enhancement of advanced healthcare services provided through the localization of modern techniques in treatment.

"The localization of therapeutic technology in the Kingdom is one of our main goals, which aligns with the Saudi Vision 2030 regarding health transformation programs,” SPA quoted AlGhofaili as saying.

“Therefore, we seek to develop local capabilities in the field of advanced medical treatment and technologies by enhancing cooperation with national and international institutions,” he added.